SlideShare a Scribd company logo
1 of 94
The Beauty of Mathematics 1 x 9 + 2 = 1112 x 9 + 3 = 111123 x 9 + 4 = 11111 234 x 9 + 5 = 1111112345 x 9 + 6 = 111111123456 x 9 + 7 = 11111111234567 x 9 + 8 = 1111111112345678 x 9 + 9 = 111111111123456789 x 9 +10= 1111111111 1 x 8 + 1 = 912 x 8 + 2 = 98123 x 8 + 3 = 9871234 x 8 + 4 = 987612345 x 8 + 5 = 98765123456 x 8 + 6 = 9876541234567 x 8 + 7 = 987654312345678 x 8 + 8 = 98765432123456789 x 8 + 9 = 987654321 9 x 9 + 7 = 8898 x 9 + 6 = 888987 x 9 + 5 = 88889876 x 9 + 4 = 8888898765 x 9 + 3 = 888888987654 x 9 + 2 = 88888889876543 x 9 + 1 = 8888888898765432 x 9 + 0 = 888888888
And look at this symmetry: 1 x 1 = 111 x 11 = 121111 x 111 = 123211111 x 1111 = 123432111111 x 11111 = 123454321111111 x 111111 = 1234565432111111 11 x 1111111 = 123456765432111111111 x 11111111 = 123456787654321111111111 x 111111111=12345678987654321
PROJECT TITLE  Estimation Of The Age Distribution Of Patients Operated And Effect Of Salmonella Typhi On The Incidence Of Typhoid Complications At The Main Surgical Theatre Supervisor Mr. S. K. Appiah
6/9/2008 4 INTRODUCTION ,[object Object],performing ,[object Object]
 The ministry of health ensure well being of the populace ,[object Object]
An Interview With A Medical (Surgical) Doctor ,[object Object]
Find certain conditions that exist in this hospital,[object Object]
What category of surgery is high?
What proportion of the patients were females?
What are the major complications?
Probable factors that influence one of the complications?,[object Object]
Most typhoid patients undergo surgery
The mean age of the patients is in the thirty’s,[object Object]
Typhoid fever in patients is highest in adolescents and young adults
Disease is generally highest in children aged 3 - 9 years,[object Object]
To estimate the average age of patients and age range who visit the department
To determine the ratio of males to females
To determine the ratioof general surgery to pediatric surgery
To know the complications frequently observed ,[object Object]
To seek sex-relation
Whether the environment or location of patients influence the number of cases.
Does the age of persons have anything to do with the complication?
Has acquired immunity play a role? ,[object Object]
January 2006 to October 2007,[object Object]
   SPSS
   Minitab,[object Object]
TYPHOID FEVER is also known as  ENTERIC FEVER
ENDEMIC Developing Countries AFRICA & South America
CAUSE bacterium Salmonella Typhi
TRANSMISSION WATERBORNE OR FOODBORNE
SYMPTOMS ,[object Object]
 Headache
 Sore throat
 Constipation
 Joint pain
 Abdominal pain
 Loss of appetite
 Fatigue
 Rose spots,[object Object]
COMPLICATIONS ,[object Object]
   Peritonitis
   Encephalopathy
   Intestinal hemorrhage
   Hepatosplenomegaly
   Diarrhea,[object Object]
KOMFO ANOKYE TEACHING HOSPITAL (KATH) ,[object Object]
LARGEST in the northern sector
 also known as GEE,[object Object]
A  REFERRAL HOSPITAL having  POLYCLINIC as well
THEIR VISION  To become a medical centre of excellence offering Clinical and Non-Clinical services of the highest quality standards comparable to any international standards within 5 years (2003-2008)
THEIR MISSION  “to provide quality services to meet the needs and expectations of all clients. This will be achieved through well-motivated and committed staff applying best practices and innovation”.
THEATRES ,[object Object]
  A1 Theatre
  Poly Theatre,[object Object]
  Urology 
  Neurosurgery
  ENT, Eye
  Paediatric Surgery
  Plastic Surgery
  Gynaecology,[object Object]
OVERVIEW OF CONCEPTS 6/9/2008 32 ,[object Object]
Why sampling over complete  enumeration:-saves time, reduce cost ,saves labour,[object Object],[object Object]
 Used to test the claim about the average age obtained in stratification and the average age obtained by the random sample  generated by minitab
(Null hypothesis)
(Alternate hypothesis) ,[object Object]
 The use of P-values in hypothesis testing :- 
P-value as the smallest level  at which the data is significant.
State if the null hypothesis was or was not rejected at a specified α -value or level of significance,[object Object]
   In many engineering and industrial experiments, the experimenter already knows that the means  µ1differ µ2, consequently, the hypothesis testing on  is of little interest.
The experimenter would usually be more interested in a confidence interval on the difference in means . The interval     is called  a                  percent confidence interval for the parameter.
CORRELATION ANALYSIS 6/9/2008 37 CONCERNED WITH THE STRENGTH OF ASSOCIATION BETWEEN THE VARIABLE OF INTEREST AND THE OTHERS   An error term which caters for the errors due to chance  and neglected  factors which we assume are not important
CORRELATION COEFFICIENT 6/9/2008 38 ,[object Object], Pearson Product – Moment ,[object Object]
Spearman’s Rank Correlation Coefficient
This is used when the data is ranked,[object Object]
TYPES OF REGRESSION MODEL 6/9/2008 40    Regression models are classified according to the number of predicted variables and also the form of the regression function. ,[object Object]
  Multiple regression model,[object Object]
ESTIMATION OF LINEAR REGRESSION MODEL 6/9/2008 42 ,[object Object],[object Object]
ANALYSIS OF VARIANCE IN REGRESSION MODEL 6/9/2008 44 The application of analysis of variance (ANOVA) in regression analysis is based on the partitioning of the total variation and its degree of freedom into components.
DEFINITION OF SOME TERMS(ANOVA):- 6/9/2008 45 ,[object Object]
The total sum of squares of deviation (SSyy,  ) is a measure of dispersion of the total variation in the observed values, y.
The explained sum of squares, (SSR ), measures the amount of the total deviation in the observed values of y that is accounted for by the linear relationship between the observed  values of x and y. This is also referred to as sum of squares due to the linear regression model.
The unexplained sum of squares is a measure of dispersion of the observed y values about the regression which is sometimes called the error residual sum of squares (SSE  ). 
COEFFICIENT OF DETERMINATION 6/9/2008 46 r2 is called the coefficient of determination which is explained variation expressed as fraction of total variation. It is also defined as a square of the correlation coefficient.
6/9/2008 47 MULTIPLE REGRESSION ANALYSIS ,[object Object]
The analysis involves a large array of data system of equations which are conveniently and effectively performed in matrix
When you have q linear combinations of the k random variables X 1 , X2…., X k .     ,[object Object]
6/9/2008 49
6/9/2008 50 MULTIPLE    LINEAR REGRESSIONMODEL ,[object Object],[object Object]
6/9/2008 52
THE BEAUTY OF MATHEMATICS ANALYSIS OF DATA AND DISCUSSION  6/9/2008 53
ANALYSIS OF DATA AND DISCUSSION  6/9/2008 54 “An unexamined life is not worth living”, similarly an unexamined organization will not be able to move forward in the right direction    At the end of this analysis, we will be able to make well informed decisions as to; ,[object Object]
Which class or nature of surgical equipments or devises that should not be limited in number.
Which complications will need to be attended by the ministry of health.,[object Object]

More Related Content

What's hot

Lesson 6 Nonparametric Test 2009 Ta
Lesson 6 Nonparametric Test 2009 TaLesson 6 Nonparametric Test 2009 Ta
Lesson 6 Nonparametric Test 2009 TaSumit Prajapati
 
Degrees of freedom
Degrees of freedomDegrees of freedom
Degrees of freedomMacVasquez
 
Statistics For Data Analytics - Multiple & logistic regression
Statistics For Data Analytics - Multiple & logistic regression Statistics For Data Analytics - Multiple & logistic regression
Statistics For Data Analytics - Multiple & logistic regression Shrikant Samarth
 
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIOODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIODr.Benny PV
 
Chi square test final
Chi square test finalChi square test final
Chi square test finalHar Jindal
 
Anova stat 512
Anova stat 512Anova stat 512
Anova stat 512gargnisha
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratificationA M
 
F test Analysis of Variance (ANOVA)
F test Analysis of Variance (ANOVA)F test Analysis of Variance (ANOVA)
F test Analysis of Variance (ANOVA)Marianne Maluyo
 
Chapter 4(2) Hypothesisi Testing
Chapter 4(2) Hypothesisi TestingChapter 4(2) Hypothesisi Testing
Chapter 4(2) Hypothesisi TestingSumit Prajapati
 
parametric test of difference z test f test one-way_two-way_anova
parametric test of difference z test f test one-way_two-way_anova parametric test of difference z test f test one-way_two-way_anova
parametric test of difference z test f test one-way_two-way_anova Tess Anoza
 
Repeated events analyses
Repeated events analysesRepeated events analyses
Repeated events analysesMike LaValley
 

What's hot (20)

Chi‑square test
Chi‑square test Chi‑square test
Chi‑square test
 
Lesson 6 Nonparametric Test 2009 Ta
Lesson 6 Nonparametric Test 2009 TaLesson 6 Nonparametric Test 2009 Ta
Lesson 6 Nonparametric Test 2009 Ta
 
International Journal of Pharmaceutica Analytica Acta
International Journal of Pharmaceutica Analytica ActaInternational Journal of Pharmaceutica Analytica Acta
International Journal of Pharmaceutica Analytica Acta
 
Posthoc
PosthocPosthoc
Posthoc
 
Degrees of freedom
Degrees of freedomDegrees of freedom
Degrees of freedom
 
Statistics For Data Analytics - Multiple & logistic regression
Statistics For Data Analytics - Multiple & logistic regression Statistics For Data Analytics - Multiple & logistic regression
Statistics For Data Analytics - Multiple & logistic regression
 
Bio statistics 1
Bio statistics 1Bio statistics 1
Bio statistics 1
 
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIOODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
 
Chi square test
Chi square testChi square test
Chi square test
 
Biostatistics in Bioequivalence
Biostatistics in BioequivalenceBiostatistics in Bioequivalence
Biostatistics in Bioequivalence
 
Chi square test final
Chi square test finalChi square test final
Chi square test final
 
Anova stat 512
Anova stat 512Anova stat 512
Anova stat 512
 
Displaying your results
Displaying your resultsDisplaying your results
Displaying your results
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification
 
F test Analysis of Variance (ANOVA)
F test Analysis of Variance (ANOVA)F test Analysis of Variance (ANOVA)
F test Analysis of Variance (ANOVA)
 
Chapter 4(2) Hypothesisi Testing
Chapter 4(2) Hypothesisi TestingChapter 4(2) Hypothesisi Testing
Chapter 4(2) Hypothesisi Testing
 
parametric test of difference z test f test one-way_two-way_anova
parametric test of difference z test f test one-way_two-way_anova parametric test of difference z test f test one-way_two-way_anova
parametric test of difference z test f test one-way_two-way_anova
 
Z test
Z testZ test
Z test
 
The t Test for Two Related Samples
The t Test for Two Related SamplesThe t Test for Two Related Samples
The t Test for Two Related Samples
 
Repeated events analyses
Repeated events analysesRepeated events analyses
Repeated events analyses
 

Similar to Undergraduate Research work

Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...cambridgeWD
 
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...cambridgeWD
 
STRATOS ISCB 2019: Ruth Keogh
STRATOS ISCB 2019: Ruth KeoghSTRATOS ISCB 2019: Ruth Keogh
STRATOS ISCB 2019: Ruth KeoghRuthKeogh2
 
Sampling_Distribution_stat_of_Mean_New.pptx
Sampling_Distribution_stat_of_Mean_New.pptxSampling_Distribution_stat_of_Mean_New.pptx
Sampling_Distribution_stat_of_Mean_New.pptxRajJirel
 
A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...
A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...
A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...Damian R. Mingle, MBA
 
Episode 18 : Research Methodology ( Part 8 )
Episode 18 :  Research Methodology ( Part 8 )Episode 18 :  Research Methodology ( Part 8 )
Episode 18 : Research Methodology ( Part 8 )SAJJAD KHUDHUR ABBAS
 
Undergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSK
Undergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSKUndergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSK
Undergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSKEbere Uzowuru
 
Episode 12 : Research Methodology ( Part 2 )
Episode 12 :  Research Methodology ( Part 2 )Episode 12 :  Research Methodology ( Part 2 )
Episode 12 : Research Methodology ( Part 2 )SAJJAD KHUDHUR ABBAS
 
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptxSensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptxAditiChauhan701637
 
Statistical modeling in pharmaceutical research and development
Statistical modeling in pharmaceutical research and developmentStatistical modeling in pharmaceutical research and development
Statistical modeling in pharmaceutical research and developmentPV. Viji
 
Ana Marusic - MedicReS World Congress 2011
Ana Marusic - MedicReS World Congress 2011Ana Marusic - MedicReS World Congress 2011
Ana Marusic - MedicReS World Congress 2011MedicReS
 
Sample Size Determination.23.11.2021.pdf
Sample Size Determination.23.11.2021.pdfSample Size Determination.23.11.2021.pdf
Sample Size Determination.23.11.2021.pdfstatsanjal
 
Efficiency of Prediction Algorithms for Mining Biological Databases
Efficiency of Prediction Algorithms for Mining Biological  DatabasesEfficiency of Prediction Algorithms for Mining Biological  Databases
Efficiency of Prediction Algorithms for Mining Biological DatabasesIOSR Journals
 
unmatched case control studies
unmatched case control studiesunmatched case control studies
unmatched case control studiesMrinmoy Bharadwaz
 
Improving predictions: Lasso, Ridge and Stein's paradox
Improving predictions: Lasso, Ridge and Stein's paradoxImproving predictions: Lasso, Ridge and Stein's paradox
Improving predictions: Lasso, Ridge and Stein's paradoxMaarten van Smeden
 

Similar to Undergraduate Research work (20)

Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
 
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
Clinical Trials Versus Health Outcomes Research: SAS/STAT Versus SAS Enterpri...
 
STRATOS ISCB 2019: Ruth Keogh
STRATOS ISCB 2019: Ruth KeoghSTRATOS ISCB 2019: Ruth Keogh
STRATOS ISCB 2019: Ruth Keogh
 
Sampling_Distribution_stat_of_Mean_New.pptx
Sampling_Distribution_stat_of_Mean_New.pptxSampling_Distribution_stat_of_Mean_New.pptx
Sampling_Distribution_stat_of_Mean_New.pptx
 
A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...
A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...
A discriminative-feature-space-for-detecting-and-recognizing-pathologies-of-t...
 
Episode 18 : Research Methodology ( Part 8 )
Episode 18 :  Research Methodology ( Part 8 )Episode 18 :  Research Methodology ( Part 8 )
Episode 18 : Research Methodology ( Part 8 )
 
Quantitative Synthesis I
Quantitative Synthesis IQuantitative Synthesis I
Quantitative Synthesis I
 
Undergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSK
Undergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSKUndergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSK
Undergraduate Project written by EBERE on ANALYSIS OF VARIATION IN GSK
 
Episode 12 : Research Methodology ( Part 2 )
Episode 12 :  Research Methodology ( Part 2 )Episode 12 :  Research Methodology ( Part 2 )
Episode 12 : Research Methodology ( Part 2 )
 
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptxSensitivity Analysis, Optimal Design, Population Modeling.pptx
Sensitivity Analysis, Optimal Design, Population Modeling.pptx
 
Statistical modeling in pharmaceutical research and development
Statistical modeling in pharmaceutical research and developmentStatistical modeling in pharmaceutical research and development
Statistical modeling in pharmaceutical research and development
 
Ana Marusic - MedicReS World Congress 2011
Ana Marusic - MedicReS World Congress 2011Ana Marusic - MedicReS World Congress 2011
Ana Marusic - MedicReS World Congress 2011
 
Sample Size Determination.23.11.2021.pdf
Sample Size Determination.23.11.2021.pdfSample Size Determination.23.11.2021.pdf
Sample Size Determination.23.11.2021.pdf
 
Efficiency of Prediction Algorithms for Mining Biological Databases
Efficiency of Prediction Algorithms for Mining Biological  DatabasesEfficiency of Prediction Algorithms for Mining Biological  Databases
Efficiency of Prediction Algorithms for Mining Biological Databases
 
unmatched case control studies
unmatched case control studiesunmatched case control studies
unmatched case control studies
 
9618821.pdf
9618821.pdf9618821.pdf
9618821.pdf
 
9618821.ppt
9618821.ppt9618821.ppt
9618821.ppt
 
Univariate Analysis
Univariate AnalysisUnivariate Analysis
Univariate Analysis
 
Improving predictions: Lasso, Ridge and Stein's paradox
Improving predictions: Lasso, Ridge and Stein's paradoxImproving predictions: Lasso, Ridge and Stein's paradox
Improving predictions: Lasso, Ridge and Stein's paradox
 
B02308013
B02308013B02308013
B02308013
 

Undergraduate Research work

  • 1. The Beauty of Mathematics 1 x 9 + 2 = 1112 x 9 + 3 = 111123 x 9 + 4 = 11111 234 x 9 + 5 = 1111112345 x 9 + 6 = 111111123456 x 9 + 7 = 11111111234567 x 9 + 8 = 1111111112345678 x 9 + 9 = 111111111123456789 x 9 +10= 1111111111 1 x 8 + 1 = 912 x 8 + 2 = 98123 x 8 + 3 = 9871234 x 8 + 4 = 987612345 x 8 + 5 = 98765123456 x 8 + 6 = 9876541234567 x 8 + 7 = 987654312345678 x 8 + 8 = 98765432123456789 x 8 + 9 = 987654321 9 x 9 + 7 = 8898 x 9 + 6 = 888987 x 9 + 5 = 88889876 x 9 + 4 = 8888898765 x 9 + 3 = 888888987654 x 9 + 2 = 88888889876543 x 9 + 1 = 8888888898765432 x 9 + 0 = 888888888
  • 2. And look at this symmetry: 1 x 1 = 111 x 11 = 121111 x 111 = 123211111 x 1111 = 123432111111 x 11111 = 123454321111111 x 111111 = 1234565432111111 11 x 1111111 = 123456765432111111111 x 11111111 = 123456787654321111111111 x 111111111=12345678987654321
  • 3. PROJECT TITLE Estimation Of The Age Distribution Of Patients Operated And Effect Of Salmonella Typhi On The Incidence Of Typhoid Complications At The Main Surgical Theatre Supervisor Mr. S. K. Appiah
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. What category of surgery is high?
  • 9. What proportion of the patients were females?
  • 10. What are the major complications?
  • 11.
  • 12. Most typhoid patients undergo surgery
  • 13.
  • 14. Typhoid fever in patients is highest in adolescents and young adults
  • 15.
  • 16. To estimate the average age of patients and age range who visit the department
  • 17. To determine the ratio of males to females
  • 18. To determine the ratioof general surgery to pediatric surgery
  • 19.
  • 21. Whether the environment or location of patients influence the number of cases.
  • 22. Does the age of persons have anything to do with the complication?
  • 23.
  • 24.
  • 25. SPSS
  • 26.
  • 27. TYPHOID FEVER is also known as ENTERIC FEVER
  • 28. ENDEMIC Developing Countries AFRICA & South America
  • 31.
  • 37. Loss of appetite
  • 39.
  • 40.
  • 41. Peritonitis
  • 42. Encephalopathy
  • 43. Intestinal hemorrhage
  • 44. Hepatosplenomegaly
  • 45.
  • 46.
  • 47.
  • 48. LARGEST in the northern sector
  • 49.
  • 50. A REFERRAL HOSPITAL having POLYCLINIC as well
  • 51. THEIR VISION To become a medical centre of excellence offering Clinical and Non-Clinical services of the highest quality standards comparable to any international standards within 5 years (2003-2008)
  • 52. THEIR MISSION “to provide quality services to meet the needs and expectations of all clients. This will be achieved through well-motivated and committed staff applying best practices and innovation”.
  • 53.
  • 54. A1 Theatre
  • 55.
  • 58. ENT, Eye
  • 59. Paediatric Surgery
  • 60. Plastic Surgery
  • 61.
  • 62.
  • 63.
  • 64. Used to test the claim about the average age obtained in stratification and the average age obtained by the random sample generated by minitab
  • 66.
  • 67.  The use of P-values in hypothesis testing :- 
  • 68. P-value as the smallest level at which the data is significant.
  • 69.
  • 70. In many engineering and industrial experiments, the experimenter already knows that the means µ1differ µ2, consequently, the hypothesis testing on is of little interest.
  • 71. The experimenter would usually be more interested in a confidence interval on the difference in means . The interval is called a percent confidence interval for the parameter.
  • 72. CORRELATION ANALYSIS 6/9/2008 37 CONCERNED WITH THE STRENGTH OF ASSOCIATION BETWEEN THE VARIABLE OF INTEREST AND THE OTHERS An error term which caters for the errors due to chance and neglected factors which we assume are not important
  • 73.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79. ANALYSIS OF VARIANCE IN REGRESSION MODEL 6/9/2008 44 The application of analysis of variance (ANOVA) in regression analysis is based on the partitioning of the total variation and its degree of freedom into components.
  • 80.
  • 81. The total sum of squares of deviation (SSyy, ) is a measure of dispersion of the total variation in the observed values, y.
  • 82. The explained sum of squares, (SSR ), measures the amount of the total deviation in the observed values of y that is accounted for by the linear relationship between the observed values of x and y. This is also referred to as sum of squares due to the linear regression model.
  • 83. The unexplained sum of squares is a measure of dispersion of the observed y values about the regression which is sometimes called the error residual sum of squares (SSE ). 
  • 84. COEFFICIENT OF DETERMINATION 6/9/2008 46 r2 is called the coefficient of determination which is explained variation expressed as fraction of total variation. It is also defined as a square of the correlation coefficient.
  • 85.
  • 86. The analysis involves a large array of data system of equations which are conveniently and effectively performed in matrix
  • 87.
  • 89.
  • 91. THE BEAUTY OF MATHEMATICS ANALYSIS OF DATA AND DISCUSSION 6/9/2008 53
  • 92.
  • 93. Which class or nature of surgical equipments or devises that should not be limited in number.
  • 94.
  • 98. 6/9/2008 59 Estimating frequency Distribution of age of Patients
  • 99. 6/9/2008 60 The estimate for the mean age was 28.55549 with standard error 1.281085
  • 100. 6/9/2008 61 The estimate for the mean age is 30.76648 with standard error 1.787193
  • 101. 6/9/2008 62 STRATIFICATION OF PATIENTS BY COMPLICATIONS The estimate for the mean age is 29.352 years with standard error 1.133
  • 102. 6/9/2008 63 The estimate for the mean age is 29.01362 years with standard error 0.3770333
  • 103. The Claim! The Mean Age is 29 years 6/9/2008 64
  • 104. STATISTICAL HYPOTHESIS TESTING Null Hypothesis: The Mean Age is 29 years 6/9/2008 65
  • 105. 6/9/2008 66 Descriptive Statistics: factor, formulation1 Variable N Mean Median TrMean StDev SE Mean factor 750 3.0000 3.0000 3.0000 1.4152 0.0517 formulation 750 28.973 25.000 27.872 21.557 0.787 Variable Minimum Maximum Q1 Q3 factor 1.0000 5.0000 2.0000 4.0000 formulation 1.000 96.000 10.000 43.000
  • 110. 6/9/2008 71 One-way ANOVA: formulation1 versus factor Analysis of Variance for formulation Source DF SS MS F P factor 4 842 210 0.45 0.771 Error 745 347210 466 Total 749 348051 Individual 95% CIs For Mean Based on Pooled StDev Level N Mean StDev ----------+---------+---------+------ 1 150 27.53 19.68 (-----------*----------) 2 150 28.48 21.37 (-----------*----------) 3 150 28.70 21.90 (-----------*----------) 4 150 29.47 21.47 (----------*-----------) 5 150 30.69 23.36 (----------*-----------) ----------+---------+---------+------ Pooled StDev = 21.59 27.0 30.0 33.0
  • 111. 6/9/2008 72 Multiple Comparisons Dependent Variable: age formulation of patients Mean 95% Confidence Interval Difference (J) factor (I) factor (I-J) Std. Error Sig. Lower Bound Upper Bound 2.00 1.00 Tukey HSD -.9533 2.49280 .995 -7.7698 5.8631 3.00 -1.1733 2.49280 .990 -7.9898 5.6431 4.00 -1.9400 2.49280 .937 -8.7565 4.8765 5.00 -3.1667 2.49280 .710 -9.9831 3.6498 1.00 2.00 .9533 2.49280 .995 -5.8631 7.7698 3.00 -.2200 2.49280 1.000 -7.0365 6.5965 4.00 -.9867 2.49280 .995 -7.8031 5.8298 5.00 -2.2133 2.49280 .901 -9.0298 4.6031 1.00 3.00 1.1733 2.49280 .990 -5.6431 7.9898 2.00 .2200 2.49280 1.000 -6.5965 7.0365 4.00 -.7667 2.49280 .998 -7.5831 6.0498 5.00 -1.9933 2.49280 .931 -8.8098 4.8231 1.00 4.00 1.9400 2.49280 .937 -4.8765 8.7565 2.00 .9867 2.49280 .995 -5.8298 7.8031 3.00 .7667 2.49280 .998 -6.0498 7.5831 5.00 -1.2267 2.49280 .988 -8.0431 5.5898 1.00 5.00 3.1667 2.49280 .710 -3.6498 9.9831 2.00 2.2133 2.49280 .901 -4.6031 9.0298 3.00 1.9933 2.49280 .931 -4.8231 8.8098 4.00 1.2267 2.49280 .988 -5.5898 8.0431 2.00 1.00 LSD -.9533 2.49280 .702 -5.8471 3.9404 3.00 -1.1733 2.49280 .638 -6.0671 3.7204 4.00 -1.9400 2.49280 .437 -6.8337 2.9537 5.00 -3.1667 2.49280 .204 -8.0604 1.7271 1.00 2.00 .9533 2.49280 .702 -3.9404 5.8471 3.00 -.2200 2.49280 .930 -5.1137 4.6737 4.00 -.9867 2.49280 .692 -5.8804 3.9071 5.00 -2.2133 2.49280 .375 -7.1071 2.6804 1.00 3.00 1.1733 2.49280 .638 -3.7204 6.0671 2.00 .2200 2.49280 .930 -4.6737 5.1137 4.00 -.7667 2.49280 .759 -5.6604 4.1271 5.00 -1.9933 2.49280 .424 -6.8871 2.9004 1.00 4.00 1.9400 2.49280 .437 -2.9537 6.8337 2.00 .9867 2.49280 .692 -3.9071 5.8804 3.00 .7667 2.49280 .759 -4.1271 5.6604 5.00 -1.2267 2.49280 .623 -6.1204 3.6671 1.00 5.00 3.1667 2.49280 .204 -1.7271 8.0604 2.00 2.2133 2.49280 .375 -2.6804 7.1071 3.00 1.9933 2.49280 .424 -2.9004 6.8871 4.00 1.2267 2.49280 .623 -3.6671 6.1204
  • 112. 6/9/2008 73 Each sample was used for the hypothesis testing of the claim that the mean age was 29 years. One-Sample Z: sample1 Test of mu = 29 vs mu not = 29 The assumed sigma = 21.6 Variable N Mean StDev SE Mean Sample 1 150 27.53 19.68 1.76 Variable 95.0% CI Z P Sample 1 ( 24.07, 30.98) -0.84 0.403 One-Sample Z: sample 2 Test of mu = 29 vs mu not = 29 The assumed sigma = 21.6 Variable N Mean StDev SE Mean Sample 2 150 28.48 21.37 1.76 Variable 95.0% CI Z P Sample 2 ( 25.02, 31.94) -0.29 0.768 One-Sample Z: sample 3 Test of mu = 29 vs mu not = 29 The assumed sigma = 21.6 Variable N Mean StDev SE Mean Sample 3 150 28.70 21.90 1.76 Variable 95.0% CI Z P Sample 3 ( 25.24, 32.16) -0.17 0.865 One-Sample Z: sample 4 Test of mu = 29 vs mu not = 29 The assumed sigma = 21.6 Variable N Mean StDev SE Mean Sample 4 150 29.47 21.47 1.76 Variable 95.0% CI Z P Sample 4 ( 26.01, 32.92) 0.26 0.791 One-Sample Z: sample 5 Test of mu = 29 vs mu not = 29 The assumed sigma = 21.6 Variable N Mean StDev SE Mean Sample 5 150 30.69 23.36 1.76 Variable 95.0% CI Z P Sample 5 ( 27.24, 34.15) 0.96 0.337
  • 114. 6/9/2008 75 AGE AND TYPHOID STATISTICS
  • 115. 6/9/2008 76 DATA FROM THE PEDIATRIC UNIT
  • 116. 6/9/2008 77 Regression Analysis: patients versus zongo, age, female The regression equation is patients = 4.07 + 0.42 zongo + 0.824 age + 0.500 female Predictor Coef SE Coef T P Constant 4.068 5.642 0.72 0.494 zongo 0.420 1.003 0.42 0.688 age 0.8240 0.6766 1.22 0.263 female 0.5002 0.7478 0.67 0.525 S = 5.899 R-Sq = 84.0% R-Sq(adj) = 77.2% Analysis of Variance Source DF SS MS F P Regression 3 1282.58 427.53 12.29 0.004 Residual Error 7 243.60 34.80 Total 10 1526.18
  • 118. 6/9/2008 79 Correlations: patients, zongo, age, female patients zongo age zongo 0.832 0.001 age 0.909 0.886 0.000 0.000 female 0.865 0.791 0.905 0.001 0.004 0.000 Cell Contents: Pearson correlation P-Value
  • 119. A NEED FOR MODEL MODIFICATION 6/9/2008 80
  • 120. 6/9/2008 81 THE PRODUCT TRANSFORMATION Regression Analysis: patients versus zonagefem This modification considers the product of the predictor factors as a single variable. The regression equation is patients = 24.3 + 0.00230 zonagefem Predictor Coef SE Coef T P Constant 24.293 4.256 5.71 0.000 zonagefe 0.0022960 0.0008795 2.61 0.028 S = 9.824 R-Sq = 43.1% R-Sq(adj) = 36.8% Analysis of Variance Source DF SS MS F P Regression 1 657.66 657.66 6.82 0.028 Residual Error 9 868.52 96.50 Total 10 1526.18
  • 121. 6/9/2008 82 THE SQUARE ROOT TRANSFORMATION Regression Analysis: patients versus sqrt (zonagefem) This modification considers the square root of the product of the predictor factors as a single variable. The regression equation is patients = 14.1 + 0.353 sqrt(zonagefem) Predictor Coef SE Coef T P Constant 14.079 4.162 3.38 0.008 sqrt(zon 0.35299 0.07059 5.00 0.001 S = 6.700 R-Sq = 73.5% R-Sq(adj) = 70.6% Analysis of Variance Source DF SS MS F P Regression 1 1122.2 1122.2 25.00 0.001 Residual Error 9 404.0 44.9 Total 10 1526.2
  • 122. 6/9/2008 83 THE NATURAL LOG TRANSFORMATION The regression equation is patients = - 18.5 + 6.87 Ln(zonagefem) Predictor Coef SE Coef T P Constant -18.480 5.142 -3.59 0.006 Ln(zonag 6.8658 0.6790 10.11 0.000 S = 3.704 R-Sq = 91.9% R-Sq(adj) = 91.0% Analysis of Variance Source DF SS MS F P Regression 1 1402.7 1402.7 102.24 0.000 Residual Error 9 123.5 13.7 Total 10 1526.2
  • 125. 6/9/2008 86 The regression equation is patients = - 18.5 + 6.87 Ln(zonagefem) where patients represents the number of patient admitted with typhoid at the Pediatric Unit; zonagefem represents the product of the environment, age below six years and number of females. The Ln is the natural logarithm function.
  • 126. MAJOR FINDINGS AND IMPLICATIONS 6/9/2008 87
  • 127.
  • 128. The age range which had more surgical complications was 0-9 years.
  • 129. The percentage of cases were relatively high for males. It was realized that about that 62.64 of the cases worked on were males. The ratio of males to femaleswas 1.7:1
  • 130. The complete data indicates that out of a total of 1831patients 27.1%and 22.17% suffered from hernia and typhoid complications6/9/2008 88
  • 131.
  • 132. It was also observed that 39.9% of the children with typhoid complication were aged below 16years.In other words, approximately 8.84% of the cases handled by the theatre were children below 16 years with typhoid fever.
  • 133. The ratio of the male to female was nearly 1:1 respectively
  • 134. The known dirty environs (“Zongo”) did not contribute a high percentage in the case of typhoid.6/9/2008 89
  • 135.
  • 136. Nature of the water they drink or use in cooking
  • 137. Poor keeping of the kitchen and toilet facilities
  • 139. Parent Inadequate education of nursing children 6/9/2008 90
  • 140.
  • 141. The hospital administrators should provide more equipments and surgical devices to accommodated patients especially those with age less 16 years.
  • 142. The public should be informed as to the risk of complications of people aged in interval 0-10 years so as to minimize these cases.
  • 143. Counseling on ways to minimize some of these related complications should be carried out.6/9/2008 91
  • 144.
  • 145. The Ministry of Health can help create animations (Cartoons) on our visual media stations so as to educate the children faster.
  • 146. Rural Water Projects should be encouraged in way to enhance proper distribution of water to various locations.6/9/2008 92
  • 147.
  • 148. This survey has revealed to as certain conditions at the main theatre of the KATH. The recommendations outlined, based on the survey, above should be considered so as to ensure that the health of all are stabilize6/9/2008 93

Editor's Notes

  1. THE estimate for the mean age WAS 28.55549 WITH STANDARD ERROR 1.281085
  2. the estimate for the mean age is 30.76648 WITH STANDARD ERROR 1.787193
  3. the estimate for the mean age is 29.01362 years WITH STANDARD ERROR 0.3770333 
  4. DONE TO CHECK IF THE ANOVA WAS NOT DECEIVING US
  5. After you have plotted data for Normality Test, Check for P-value.P-value < 0.05 = not normal. normal = P-value >= 0.05. Comment:since the p-value was <0.001 the age distribution was not normally distributed but skewed.(P-value=0.65>0.05)
  6. 8.84% of the cases handled by the theatre were children below 16 years with typhoid fever; this was relatively high.
  7. If any of the predictor variables is zero then the product is zero; number of patients becomes negative. Since, there exists no negative number of patients it implies the number of patients is zero. Therefore, most patients that visit the hospital and are admitted in the pediatric ward are very likely to be females aged below six years from the zongo community. All the three predictor variables have a positive influence in the number of patients admitted with typhoid in the pediatric ward as observed from the correlation analysis.